Imeros (Mepivacaine Hydrochloride)

Mepivacaine blocks voltage‑gated sodium channels on neuronal membranes, preventing the influx of sodium ions that are required for the generation and propagation of nerve impulses. By stabilizing the neuronal membrane, it inhibits the transmission of pain signals from the site of injection to the central nervous system, resulting in localized numbness.

The appropriate dose of Imeros is determined by the prescribing clinician based on the type of procedure, the site of administration, patient weight, and overall health status. Dosing guidelines are provided in the product’s prescribing information, and the healthcare professional will calculate the exact amount required for each individual case.

The safety of mepivacaine hydrochloride in pregnancy has not been definitively established, and it is classified as a category unknown. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus. Limited data are available for breastfeeding, so caution is advised.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Imeros. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Mepivacaine has a rapid onset similar to lidocaine but a slightly longer duration of action, making it suitable for procedures that require extended anesthesia without the need for a vasoconstrictor. Compared with bupivacaine, it has a lower risk of cardiotoxicity but a shorter duration, offering a balance between efficacy and safety for many clinical settings.

Imeros should be stored at ambient temperature, preferably below 25 °C, in its original sealed container. The product must be protected from direct sunlight, moisture and freezing. Before use, inspect the solution for particulate matter or discoloration; do not use if the container is compromised. Follow standard aseptic techniques when preparing for injection.

Imeros is supplied as a sterile solution for injection and is administered by a qualified healthcare professional via infiltration into the target tissue or perineural injection for a nerve block. The injection technique, volume, and concentration are selected based on the specific procedure and patient factors, ensuring effective local anesthesia while minimizing systemic exposure.

Although rare, serious adverse events can include cardiovascular toxicity such as arrhythmias or cardiac arrest, central nervous system effects like seizures, and severe allergic reactions including anaphylaxis. Prompt recognition and management of these events are essential; emergency resuscitation equipment and trained personnel should be readily available whenever mepivacaine is administered.

Imeros is contraindicated in patients with a known hypersensitivity to mepivacaine, other amide‑type local anesthetics, or any component of the formulation. It should also be avoided in individuals with severe heart block, uncontrolled epilepsy, or those receiving class I antiarrhythmic drugs unless the benefits clearly outweigh the risks. Clinical judgment is required for each patient.